. 2019 Jan 30;33(4):1023–1029. doi: 10.1038/s41375-019-0391-2

Table. 2.

Overall and risk subgroup analysis of best responses and survivals in three treatments

Treatment	All(N = 387)		Low risk(N = 118)		Medium-high risk (N = 229)
	Rate	p	Rate	p	Rate	p
CR_H
ASCT	49.7		40.6		57.0
MDex	37.7	0.001	43.8	1.000	35.8	0.023
LDex	47.5	0.797	48.0	0.638	47.3	0.267
CR_V
ASCT	66.2		62.1		70.0
MDex	38.5	0.001	58.3	0.804	32.5	< 0.001
LDex	47.7	0.008	41.7	0.097	50.0	0.022
CR_H/CR_V
ASCT	75.3		70.0		80.0
MDex	58.3	0.015	76.9	0.748	53.2	0.001
LDex	66.3	0.142	56.0	0.204	70.1	0.167
R_N
ASCT	91.5		91.4		91.5
MDex	100.0	0.188	100.0	1.000	100.0	0.295
LDex	93.8	0.755	100.0	0.543	91.8	1.000
	3y-PFS	p	3y-PFS	p	3y-PFS	p
PFS
ASCT	87.6		83.7	0.612	84.6
MDex	84.6	0.568	87.8	0.351	84.6	0.364
LDex	64.9	0.003	59.0	0.016	67.7	0.037
	3y-OS	p	3y-OS	p	3y-OS	p
OS
ASCT	94.4		96.9		92.3
MDex	90.7	0.088	94.3	0.701	89.8	0.155
LDex	83.1	0.067	95.8	0.826	78.6	0.099